June 18, 2018

First Buy-Side Client Goes Live With Eurex Lending CCP

PGGM and Morgan Stanley are in the final stages of admission and testing with a view to start transactions using Eurex Clearing’s Securities Lending CCP.

Share

First Buy-Side Client Goes Live With Eurex Lending CCP

From Eurex:

PGGM and Morgan Stanley are in the final stages of admission and testing with a view to start transactions using Eurex Clearing’s Securities Lending CCP.

We are proud to announce that the cooperative Dutch pension fund service provider PGGM is in the process of finalizing its admission as a direct participant of Eurex Clearing’s Securities Lending central counterparty (CCP).

PGGM, which offers asset management, pension fund management, policy advice and management support to institutional clients, is to start transactions with Morgan Stanley. Currently, the parties are in the closing stages of simulation testing with a view to becoming the first to use EquiLend Clearing Services’ (ECS) full connectivity offering to access our Lending CCP. The service will enable them to transmit trades agreed via Equilend to the Lending CCP.

Click here to read the full announcement from Eurex.

Media Contact

About Equilend

Equilend is a global financial technology firm offering Trading, Workflow Automation, Data & Insights, and Digital Solutions for the securities finance industry. With offices in North America, EMEA and Asia-Pacific, Equilend operates across various jurisdictions worldwide, adhering to the highest regulatory standards.

The company is committed to excellence and innovation and is consistently recognised for its contributions to the industry. Equilend is Great Place to Work Certified™ in the U.S., UK, Ireland and India and has been awarded Global Data Provider of the Year and Regulatory Solution of the Year in the Securities Finance Times Industry Excellence Awards 2025.

For more information, please visit www.equilend.com

Equilend team

Connecting
Securities Finance

By subscribing, you agree to our Privacy Policy.